Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2006-06-08 21:20 | 2006-06-06 | ASTM | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Officer; Chairman and CEO | Biological Products, (No Diagnostic Substances) | BUY | $1.26 | 8,000 | $10,080 | 573,763 | +1.4% |
| 2006-02-14 21:35 | 2006-02-13 | ASTM | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Officer; CEO and Chairman of the Board | Biological Products, (No Diagnostic Substances) | BUY | $1.67 | 3,000 | $5,010 | 565,763 | +0.5% |
| 2005-05-23 23:22 | 2005-05-20 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman, CEO | Biological Products, (No Diagnostic Substances) | SALE | $2.86 | 120,173 | $344,079 | 501,746 | -19.3% |
| 2005-05-19 23:39 | 2005-05-17 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman, CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $2.35 | 574,106 | $1,350,871 | 621,919 | -48.0% |
| 2005-02-25 01:28 | 2005-02-22 | VCEL | Vericel Corp | ARMSTRONG R DOUGLAS PHD | Director, Officer; Chairman and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $2.96 | 374,100 | $1,106,663 | 694,279 | -35.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.